Zeke Capital Advisors’s Exact Sciences EXAS Stock Holding History

Zeke Capital Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$450K	Buy	+9,092	New	+$371K	0.03%	257
2019 Q4	–	Sell	-2,833	Closed	-$256K	–	552
2019 Q3	$256K	Sell	2,833 -2,120	-43%	-$242K	0.02%	479
2019 Q2	$585K	Buy	+4,953	New	+$499K	0.06%	318
2018 Q3	–	Sell	-4,971	Closed	-$297K	–	679
2018 Q2	$297K	Sell	4,971 -785	-14%	-$42.2K	0.03%	409
2018 Q1	$232K	Buy	5,756 +88	+2%	+$4.29K	0.02%	525
2017 Q4	$298K	Buy	+5,668	New	+$303K	0.03%	395

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Zeke Capital Advisors's EXAS Position: Q4 2022 in Review

Zeke Capital Advisors opened a new position in Exact Sciences (EXAS) in Q4 2022: 9,092 shares worth $450K. The stake represents 0.03% of the portfolio and ranks #257 among its holdings. This is a return to the name: Zeke Capital Advisors previously reported a position in EXAS as recently as Q3 2019.

Zeke Capital Advisors first reported a position in EXAS in Q4 2017 and has held it in 6 quarters since. The position peaked at $585K in Q2 2019. 550 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

Zeke Capital Advisors held 9,092 shares of Exact Sciences worth $450K as of Q4 2022.
Exact Sciences was a new Zeke Capital Advisors position in Q4 2022.
Exact Sciences made up 0.03% of Zeke Capital Advisors's portfolio in Q4 2022, its #257 holding.
Zeke Capital Advisors first reported a position in Exact Sciences in Q4 2017 and has held it in 6 quarters since.
Zeke Capital Advisors's Exact Sciences position peaked at $585K in Q2 2019.
550 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.